先进制造业知识服务平台
国家科技图书文献中心机械分馆  工信部产业技术基础公共服务平台  国家中小企业公共服务示范平台

OA期刊


ISSN1942-0862
刊名Mabs
出版商Taylor & Francis Inc.
urlhttps://www.tandfonline.com/loi/kmab20
机构Taylor & Francis Ltd.



全部

2010 2011 2012 2013 2014 2015
2016 2017 2018 2019 2020 2021
2022 2023 2024 2025

2019, vol.11, no.1 2019, vol.11, no.2 2019, vol.11, no.3 2019, vol.11, no.4 2019, vol.11, no.5 2019, vol.11, no.6
2019, vol.11, no.7 2019, vol.11, no.8

题名作者出版年年卷期
Expression vector-derived heterogeneity in a therapeutic IgG4 monoclonal antibodyDouglas S. Rehder;Chris J. Wisniewski;Dengfeng Liu;Diya Ren;Dell Farnan;Matthew R. Schenauer;20192019, vol.11, no.1
High-resolution glycosylation site-engineering method identifies MICA epitope critical for shedding inhibition activity of anti-MICA antibodiesT. Noelle Lombana;Marissa L. Matsumoto;Jack Bevers III;Amy M. Berkley;Evangeline Toy;Ryan Cook;Yutian Gan;Changchun Du;Peter Liu;Paul Schnier;Wendy Sandoval;Zhengmao Ye;Jill M. Schartner;Jeong Kim;Christoph Spiess;20192019, vol.11, no.1
Evaluation of similar quality attribute characteristics in SB5 and reference product of adalimumabNayoung Lee;JongAh Joanne Lee;Hahymn Yang;Serim Baek;Soohwan Kim;Sooshin Kim;Tongkeun Lee;Dami Song;Gwangmin Park;20192019, vol.11, no.1
Antigen binding allosterically promotes Fc receptor recognitionJun Zhao;Ruth Nussinov;Buyong Ma;20192019, vol.11, no.1
Comprehensive characterisation of the heterogeneity of adalimumab via charge variant analysis hyphenated on-line to native high resolution Orbitrap mass spectrometryFlorian Füssl;Anne Trappe;Ken Cook;Kai Scheffler;Oliver Fitzgerald;Jonathan Bones;20192019, vol.11, no.1
Deamidation and isomerization liability analysis of 131 clinical-stage antibodiesXiaojun Lu;R. Paul Nobrega;Heather Lynaugh;Tushar Jain;Kyle Barlow;Todd Boland;Arvind Sivasubramanian;Maximiliano Vásquez;Yingda Xu;20192019, vol.11, no.1
Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activityFabian Richter;Kirstin A. Zettlitz;Oliver Seifert;Andreas Herrmann;Peter Scheurich;Klaus Pfizenmaier;Roland E. Kontermann;20192019, vol.11, no.1
Anti-PD1 ‘SHR-1210ʹ aberrantly targets pro-angiogenic receptors and this polyspecificity can be ablated by paratope refinementWilliam J.J. Finlay;James E. Coleman;Jonathan S. Edwards;Kevin S. Johnson;20192019, vol.11, no.1
The first World Health Organization International Standard for infliximab products: A step towards maintaining harmonized biological activityClive Metcalfe;Thomas Dougall;Chris Bird;Peter Rigsby;Marie-Emmanuelle Behr-Gross;Meenu Wadhwa;20192019, vol.11, no.1
Evolution of a comprehensive, orthogonal approach to sequence variant analysis for biotherapeuticsT. Jennifer Lin;Kathryn M. Beal;Paul W. Brown;Heather S. DeGruttola;Mellisa Ly;Wenge Wang;Chia H. Chu;Robert L. Dufield;Gerald F. Casperson;James A. Carroll;Olga V. Friese;Bruno Figueroa Jr.;Lisa A. Marzilli;Karin Anderson;Jason C. Rouse;20192019, vol.11, no.1
12